🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
This is a multicenter, double-blind, randomized, placebo-controlled study d...
Status
Terminated
Location
Northwell Health
Start Date
2015-12-30
Trial ID
NCT02545283
Treatments Being Tested
Phase II randomized placebo-controlled study to assess the impact on outcom...
Status
Active Not Recruiting
Location
CHU ANGERS - Maladies du sang
Start Date
2018-10-11
Trial ID
NCT03603795
Treatments Being Tested
This bridging study will evaluate the efficacy of uproleselan, a specific E...
Status
Terminated
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-11-17
Trial ID
NCT05054543
Treatments Being Tested
The purpose of this study is to determine if a combination of nintedanib+ i...
Status
Completed
Location
Yale University
Start Date
2016-07-21
Trial ID
NCT02665143
Treatments Being Tested
This phase II trial studies the effect of ascorbic acid and combination che...
Status
Recruiting
Location
Mayo Clinic Health Systems-Mankato
Start Date
2018-03-23
Trial ID
NCT03418038
Treatments Being Tested
The purpose of this study is to assess whether there is a survival benefit ...
Status
Completed
Location
Southern Cancer Center
Start Date
2007-09
Trial ID
NCT00528333
Treatments Being Tested
This study evaluated the efficacy and safety of midostaurin in combination ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-04-06
Trial ID
NCT03280030
Treatments Being Tested
The purpose of this study was to confirm the preliminary evidence from earl...
Status
Completed
Location
University of Chicago Medical Center .
Start Date
2018-07-20
Trial ID
NCT03512197
Treatments Being Tested
To investigate the efficacy, safety, and pharmacokinetics of intravenous vo...
Status
Completed
Location
University of California
Start Date
2013-01-29
Trial ID
NCT01721876
Treatments Being Tested